surmount-1 trial tirzepatide obesity without diabetes SURMOUNT-1: Adults achieve weight loss of 16% or more at 72 weeks with SURMOUNT-1

Get started 80% of patients start to see health improvements in 30 days1 Weight loss 8% Average weight loss for patients not on GLP-1s after 12 months A1C Reduction 1.3% Average reduction in A1C after 12 months Cholesterol Reduction 27mg/dL Average reduction in LDL cholesterol after 12 months Blood Pressure Reduction 21 mmHg Average reduction in systolic blood pressure after 12 months Patient Satisfaction & Goal Achievement 94% of patients would recommend Nourish to a friend or family member 90% of patients achieve progress towards their health goals after just 3 months 1

It fits as a study that tempers previous enthusiasm

The Case for Using Both Together The BPC-157 vs

These practical strategies help translate dosage knowledge into consistent, accurate practice

One of its greatest advantage is the quick effect and self-injection method

Incorporating such noninvasive tools into routine screening is critical for identifying at-risk MASLD patients with T2DM before progression to advanced liver disease (69)